Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Definitive Healthcare (DH) Cost of Revenue (2020 - 2025)

Historic Cost of Revenue for Definitive Healthcare (DH) over the last 6 years, with Q3 2025 value amounting to $20.4 million.

  • Definitive Healthcare's Cost of Revenue rose 124.19% to $20.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $81.9 million, marking a year-over-year decrease of 593.52%. This contributed to the annual value of $83.8 million for FY2024, which is 1134.72% down from last year.
  • According to the latest figures from Q3 2025, Definitive Healthcare's Cost of Revenue is $20.4 million, which was up 124.19% from $20.5 million recorded in Q2 2025.
  • Definitive Healthcare's Cost of Revenue's 5-year high stood at $24.7 million during Q2 2023, with a 5-year trough of $11.7 million in Q1 2021.
  • Over the past 5 years, Definitive Healthcare's median Cost of Revenue value was $21.2 million (recorded in 2022), while the average stood at $20.3 million.
  • In the last 5 years, Definitive Healthcare's Cost of Revenue soared by 8305.65% in 2022 and then plummeted by 1369.63% in 2024.
  • Quarter analysis of 5 years shows Definitive Healthcare's Cost of Revenue stood at $17.4 million in 2021, then surged by 35.31% to $23.5 million in 2022, then increased by 0.35% to $23.6 million in 2023, then decreased by 13.7% to $20.4 million in 2024, then increased by 0.04% to $20.4 million in 2025.
  • Its Cost of Revenue stands at $20.4 million for Q3 2025, versus $20.5 million for Q2 2025 and $20.7 million for Q1 2025.